BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25775019)

  • 1. Is peri-operative steroid replacement therapy necessary for the pituitary adenomas treated with surgery? A systematic review and meta analysis.
    Tohti M; Li J; Zhou Y; Hu Y; Yu Z; Ma C
    PLoS One; 2015; 10(3):e0119621. PubMed ID: 25775019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
    McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF
    World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.
    Jayasena CN; Gadhvi KA; Gohel B; Martin NM; Mendoza N; Meeran K; Dhillo WS
    Clin Chem; 2009 May; 55(5):972-7. PubMed ID: 19282356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary?
    Hout WM; Arafah BM; Salazar R; Selman W
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1208-12. PubMed ID: 3372683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transphenoidal surgery without steroid replacement in patients with morning serum cortisol below 9 μg/dl (250 Nmol/l).
    De Tommasi C; Goguen J; Cusimano MD
    Acta Neurochir (Wien); 2012 Oct; 154(10):1903-15. PubMed ID: 22922981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety.
    Sterl K; Thompson B; Goss CW; Dacey RG; Rich KM; Zipfel GJ; Chicoine MR; Kim AH; Silverstein JM
    Neurosurgery; 2019 Aug; 85(2):E226-E232. PubMed ID: 30325449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational use of glucocorticoid during pituitary surgery--a pilot study.
    Bhansali A; Dutta P; Bhat MH; Mukherjee KK; Rajput R; Bhadada S
    Indian J Med Res; 2008 Sep; 128(3):294-9. PubMed ID: 19052341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?
    Auchus RJ; Shewbridge RK; Shepherd MD
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):21-7. PubMed ID: 9059554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-operative glucocorticoid replacement therapy in transsphenoidal pituitary adenoma surgery: a prospective controlled study.
    Kristof RA; Wichers M; Haun D; Redel L; Klingmüller D; Schramm J
    Acta Neurochir (Wien); 2008 Apr; 150(4):329-35; discussion 335. PubMed ID: 18309452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can basal cortisol measurement be an alternative to the insulin tolerance test in the assessment of the hypothalamic-pituitary-adrenal axis before and after pituitary surgery?
    Karaca Z; Tanriverdi F; Atmaca H; Gokce C; Elbuken G; Selcuklu A; Unluhizarci K; Kelestimur F
    Eur J Endocrinol; 2010 Sep; 163(3):377-82. PubMed ID: 20530552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of withholding hydrocortisone during preoperative periods in pituitary adenomas patients with an intact HPA axis: A meta-analysis of randomized controlled trials.
    Lin F; Su Y; Zhang X; Liang B; Qin M
    Neuro Endocrinol Lett; 2023 Jun; 44(3):131-139. PubMed ID: 37392440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UTILITY OF A GLUCOCORTICOID SPARING STRATEGY IN THE MANAGEMENT OF PATIENTS FOLLOWING TRANSSPHENOIDAL SURGERY.
    Jia X; Pendharkar AV; Loftus P; Dodd RL; Chu O; Fraenkel M; Katznelson L
    Endocr Pract; 2016 Sep; 22(9):1033-9. PubMed ID: 27124693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary.
    Wentworth JM; Gao N; Sumithran KP; Maartens NF; Kaye AH; Colman PG; Ebeling PR
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):29-35. PubMed ID: 18088287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The postoperative cortisol stress response following transsphenoidal pituitary surgery: a potential screening method for assessing preserved pituitary function.
    Zada G; Tirosh A; Huang AP; Laws ER; Woodmansee WW
    Pituitary; 2013 Sep; 16(3):319-25. PubMed ID: 22915289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of day 1 early morning cortisol to predict the need for glucocorticoid replacement after pituitary surgery.
    Bondugulapati LN; Campbell C; Chowdhury SR; Goetz P; Davies JS; Rees DA; Hayhurst C
    Br J Neurosurg; 2016; 30(1):76-9. PubMed ID: 26313503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas.
    Cozzi R; Lasio G; Cardia A; Felisati G; Montini M; Attanasio R
    J Endocrinol Invest; 2009 May; 32(5):460-4. PubMed ID: 19494715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the pituitary-adrenal axis before, during and after pituitary adenomectomy. Is perioperative glucocorticoid therapy necessary?
    García-Luna PP; Leal-Cerro A; Rocha JL; Trujillo F; Garcia-Pesquera F; Astorga R
    Acta Endocrinol (Copenh); 1990 Jan; 122(1):83-8. PubMed ID: 2154904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomas.
    Kokshoorn NE; Romijn JA; Roelfsema F; Rambach AH; Smit JW; Biermasz NR; Pereira AM
    Pituitary; 2012 Sep; 15(3):436-44. PubMed ID: 21904912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of Withholding Perioperative Hydrocortisone for Patients With Pituitary Adenomas With an Intact Hypothalamus-Pituitary-Adrenal Axis: A Randomized Clinical Trial.
    Guo X; Zhang D; Pang H; Wang Z; Gao L; Wang Y; Ma W; Lian W; Xing B;
    JAMA Netw Open; 2022 Nov; 5(11):e2242221. PubMed ID: 36383383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective perioperative steroid supplementation protocol in patients undergoing endoscopic transsphenoidal surgery for pituitary adenomas.
    Chacko SR; Abraham AP; Asha HS; Kapoor N; Rajaratnam S; Chacko AG
    Acta Neurochir (Wien); 2020 Oct; 162(10):2381-2388. PubMed ID: 32772164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.